Cargando…

Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction

Introduction: Antibody treatment with anti-thymocyte globulin (ATG) has been shown to be cardioprotective. We aimed to evaluate which single anti-T-cell epitope antibody alters chemokine expression at a level similar to ATG and identified CD3, which is a T-cell co-receptor mediating T-cell activatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wernly, Bernhard, Paar, Vera, Aigner, Achim, Pilz, Patrick M, Podesser, Bruno K, Förster, Martin, Jung, Christian, Pinon Hofbauer, Josefina, Tockner, Birgit, Wimmer, Monika, Kraus, Theo, Motloch, Lukas J, Hackl, Matthias, Hoppe, Uta C, Kiss, Attila, Lichtenauer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072364/ https://www.ncbi.nlm.nih.gov/pubmed/31991811 http://dx.doi.org/10.3390/cells9020295

Ejemplares similares

MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
por: Boxhammer, Elke, et al.
Publicado: (2023)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019)

Assessment of Cardiac Remodeling—A Chance for Novel Cardiac Biomarkers?
por: Jirak, Peter, et al.
Publicado: (2020)

Regenerative Cardiovascular Therapies: Stem Cells and Beyond
por: Wernly, Bernhard, et al.
Publicado: (2019)

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest
por: Rezar, Richard, et al.
Publicado: (2022)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage
por: Topf, Albert, et al.
Publicado: (2022)

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
por: Jirak, Peter, et al.
Publicado: (2020)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
por: Topf, Albert, et al.
Publicado: (2021)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Carcinoid heart disease involving the left heart: a case report and biomarker analysis
por: Lichtenauer, Michael, et al.
Publicado: (2019)

sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research
por: Wernly, Sarah, et al.
Publicado: (2023)

Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
por: Jirak, Peter, et al.
Publicado: (2017)

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Correction to: The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction
por: Schernthaner, Christiana, et al.
Publicado: (2017)

Visualization and appearance of artifacts of leadless pacemaker systems in cardiac MRI: An experimental ex vivo study
por: Edlinger, Christoph, et al.
Publicado: (2018)

Echokardiographieuntersuchungen in Zeiten der COVID-19-Pandemie: Internationale Empfehlungen und Umsetzung
por: Lichtenauer, Michael, et al.
Publicado: (2020)

Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease
por: Edlinger, Christoph, et al.
Publicado: (2018)

MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?
por: Mirna, Moritz, et al.
Publicado: (2019)

A novel ex-vivo isolated rabbit heart preparation to explore the cardiac effects of cervical and cardiac vagus nerve stimulation
por: Kronsteiner, Bettina, et al.
Publicado: (2023)

Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study
por: Rezar, Richard, et al.
Publicado: (2021)

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review
por: Topf, Albert, et al.
Publicado: (2021)

Partial oral antibiotic therapy is non-inferior to intravenous therapy in non-critically ill patients with infective endocarditis: Review and meta-analysis
por: Rezar, Richard, et al.
Publicado: (2020)

Overview of Current International Recommendations for Echocardiography Exams During the Covid-19 Pandemic and Its Local Implementation in Austria
por: Lichtenauer, Michael, et al.
Publicado: (2021)

Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Boxhammer, Elke, et al.
Publicado: (2022)

New Cardiovascular Biomarkers in Ischemic Heart Disease—GDF-15, A Probable Predictor for Ejection Fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism – A review and a case report
por: Topf, Albert, et al.
Publicado: (2021)

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
por: Jirak, Peter, et al.
Publicado: (2022)

Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance
por: Wernly, Bernhard, et al.
Publicado: (2017)

Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis?
por: Wernly, Bernhard, et al.
Publicado: (2016)

Hyperlactatemia and altered lactate kinetics are associated with excess mortality in sepsis: A multicenter retrospective observational study
por: Rezar, Richard, et al.
Publicado: (2022)

Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction
por: Kopp, Kristen, et al.
Publicado: (2023)

Conundrum of Classifying Subtypes of Pulmonary Hypertension—Introducing a Novel Approach to Classify “Borderline” Patients in a Population with Severe Aortic Stenosis Undergoing TAVI
por: Boxhammer, Elke, et al.
Publicado: (2022)

Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
por: Mirna, Moritz, et al.
Publicado: (2021)

Case report: Short-long-short mechanism triggering sustained ventricular tachycardia in a patient with a single-chamber ICD but inhibiting antitachycardia therapy
por: Schernthaner, Christiana, et al.
Publicado: (2022)

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
por: Topf, Albert, et al.
Publicado: (2022)

Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study
por: Mirna, Moritz, et al.
Publicado: (2020)

Mortality after cardiopulmonary resuscitation on a medical ICU: A sex-specific outcome analysis
por: Rezar, Richard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8855kgpl12kpmc8vuup4ul6gb